What is ZINBRYTA:

ZINBRYTA is a medicine that contains the active substance Daclizumab and is available as PFS.

In how many countries ZINBRYTA is approved for marketing?

ZINBRYTA is available/approved in USA and Europe. We can help you to access it in India.

What is ZINBRYTA used for?

ZINBRYTA is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of ZINBRYTA should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.